We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Autohome
ATHM
$2.62B
| $116M | 0.29% |
1,532,431
-131,350
| -8% | -$10.3M |
|
77
GSK
GSK
$106B
| $113M | 0.28% |
2,224,586
-487,939
| -18% | -$25M |
|
|
78
Public Service Enterprise Group
PEG
$38.9B
| $112M | 0.28% |
2,280,133
+2,169,724
| +1,965% | +$108M |
|
79
British American Tobacco
BTI
$136B
| $111M | 0.27% |
2,853,980
+280,086
| +11% | +$10.7M |
|
80
Travelers Companies
TRV
$82.1B
| $110M | 0.27% |
963,294
+150,660
| +19% | +$15.9M |
|
81
TJX Companies
TJX
$180B
| $110M | 0.27% |
2,170,119
-206,911
| -9% | -$10.4M |
|
82
Johnson & Johnson
JNJ
$643B
| $109M | 0.27% |
772,268
+91,927
| +14% | +$13.4M |
|
|
DOCU
83
DocuSign
DOCU
$11.2B
| $108M | 0.27% |
628,853
-125,777
| -17% | -$15.9M |
|
84
West Pharmaceutical
WST
$23.5B
| $108M | 0.27% |
476,517
-179,485
| -27% | -$35.3M |
|
85
Hamilton Lane
HLNE
$3.89B
| $107M | 0.27% |
1,595,600
+201,592
| +14% | +$12.7M |
|
86
Vertex Pharmaceuticals
VRTX
$124B
| $106M | 0.26% |
364,535
-34,322
| -9% | -$9.31M |
|
87
Vodafone
VOD
$37.2B
| $106M | 0.26% |
6,633,784
+927,880
| +16% | +$14M |
|
88
Meta Platforms (Facebook)
META
$1.51T
| $105M | 0.26% |
462,318
-38,721
| -8% | -$8.08M |
|
89
argenx
ARGX
$55.1B
| $105M | 0.26% |
465,025
+100,414
| +28% | +$17.8M |
|
90
Walt Disney
DIS
$171B
| $105M | 0.26% |
938,729
+22,479
| +2% | +$2.48M |
|
91
Unilever
UL
$143B
| $105M | 0.26% |
1,693,732
-253,328
| -13% | -$15.1M |
|
92
Idexx Laboratories
IDXX
$45.1B
| $104M | 0.26% |
316,126
+22,775
| +8% | +$6.59M |
|
93
Alector
ALEC
$170M
| $104M | 0.26% |
4,267,354
-162,343
| -4% | -$4.48M |
|
94
Teladoc Health
TDOC
$1.68B
| $103M | 0.26% |
540,728
-167,606
| -24% | -$29.4M |
|
95
Q2 Holdings
QTWO
$3.84B
| $103M | 0.25% |
1,198,400
+80,000
| +7% | +$6.15M |
|
|
GWPH
96
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $101M | 0.25% |
823,400
+69,968
| +9% | +$7.94M |
|
97
Accenture
ACN
$107B
| $100M | 0.25% |
465,684
-61,740
| -12% | -$11.7M |
|
|
DVAX
98
DELISTED
Dynavax Technologies
DVAX
| $99M | 0.25% |
11,166,800
+1,400,000
| +14% | +$7.08M |
|
|
INFO
99
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $98.5M | 0.24% |
1,305,309
-32,987
| -2% | -$2.25M |
|
100
TC Energy
TRP
$70.3B
| $96.8M | 0.24% |
2,258,313
+631,507
| +39% | +$28.3M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.